Clinical Investigation of the Quality of Life Benefit of Using a Home Walking Exoskeleton for a Population of Multiple Sclerosis Patients.

Study acronym: EXHOMESEP
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Enrollment closed, study ongoing
    • Primary completion date changed from estimate of Oct 2026 to Sep 18, 2026
    • Study completion date changed from estimate of Oct 2, 2026 to Sep 18, 2026
  2. Primary endpoints: details revised at 1 of 1 entry Show 5 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Eligibility criteria expanded, about 30 words
    • Site details revised at 6 of 6 sites
    • Publications: details revised at 1 of 1 entry
    • Study description expanded, about 2 words
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Feb 2026 to Oct 2026
    • Start date changed from estimate of May 2, 2023 to Feb 1, 2024
    • Study completion date: Feb 2, 2026 to Oct 2, 2026
    • Site details revised at 6 of 6 sites
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical investigation is to evaluate the effectiveness of home use of a lightweight robotic lower limb exoskeleton as a walking aid device on quality of life in patients with multiple sclerosis with gait disorders. Participants will wear an exoskeleton (Keeogo) for 8 weeks at home during the experimental phase. This phase is compared to an 8-week control phase at home with advice on regular physical activity adapted to their abilities.
Trial Details
NCT Number NCT05835622
Lead Sponsor Pôle Saint Hélier
Conditions
(from sponsor)		 Multiple Sclerosis
Related terms Multiple Sclerosis
Enrollment 28 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov